IdiQ Sentinel System 3.0: Program Management Organization (PMO) 2
ID: RFP75F40124R00181 • Type: Synopsis Solicitation
Overview
Response Deadline
Aug. 30, 2024, 2:00 p.m. EDT
Past Due
Posted
Aug. 19, 2024, 3:19 p.m. EDT (updated: Aug. 27, 2024, 1:43 p.m. EDT)
Set Aside
Women-Owned Small Business (WOSB)
Place of Performance
Silver Spring, MD
United States
Source
Current SBA Size Standard
$19.5 Million
Est. Level of Competition
Average
Vehicle Type
Indefinite Delivery Contract
Signs of Shaping
61% of obligations for similar contracts within the Food and Drug Administration were awarded full & open.
On 8/19/24 Center for Drug Evaluation and Research issued Synopsis Solicitation RFP75F40124R00181 for IdiQ Sentinel System 3.0: Program Management Organization (PMO) due 8/30/24.
The opportunity was issued with a Women-Owned Small Business (WOSB) set aside with NAICS 541990 (SBA Size Standard
$19.5 Million) and PSC R499.
Primary Contact
Secondary Contact
Documents
Posted documents for Synopsis Solicitation RFP75F40124R00181
Question & Answer
Opportunity Lifecycle
Procurement notices related to Synopsis Solicitation RFP75F40124R00181
Award Notifications
Agency published notification of awards for Synopsis Solicitation RFP75F40124R00181
Incumbent or Similar Awards
Contracts Similar to Synopsis Solicitation RFP75F40124R00181
Potential Bidders and Partners
Awardees that have won contracts similar to Synopsis Solicitation RFP75F40124R00181
Similar Active Opportunities
Open contract opportunities similar to Synopsis Solicitation RFP75F40124R00181
Additional Details
Source Agency Hierarchy
HEALTH AND HUMAN SERVICES, DEPARTMENT OF > FOOD AND DRUG ADMINISTRATION > FDA CENTER FOR DRUG EVALUATION AND RESEARCH
FPDS Organization Code
7524-75DKKN
Source Organization Code
500024274
Last Updated
Sept. 14, 2024
Last Updated By
howard.yablon@fda.hhs.gov
Archive Date
Sept. 14, 2024